Literature DB >> 4736825

Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS).

G Sherwood, R M Blaese.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4736825      PMCID： PMC1553734     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  FAMILIAL LYMPHOPENIA WITH AGAMMAGLOBULINEMIA: AN ATTEMPT AT TREATMENT BY IMPLANTATION OF FETAL THYMUS.

Authors:  W H HITZIG; H E KAY; H COTTIER
Journal:  Lancet       Date:  1965-07-24       Impact factor: 79.321

2.  Treatment of chronic mucocutaneous candidiasis with leucocytes from HL-A compatible sibling.

Authors:  H Valdimarsson; P D Moss; P J Holt; J R H OBBS
Journal:  Lancet       Date:  1972-02-26       Impact factor: 79.321

3.  Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity.

Authors:  M D Cooper; H P Chae; J T Lowman; W Krivit; R A Good
Journal:  Am J Med       Date:  1968-04       Impact factor: 4.965

4.  The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition.

Authors:  R M Blaese; W Strober; R S Brown; T A Waldmann
Journal:  Lancet       Date:  1968-05-18       Impact factor: 79.321

5.  In vitro cytotoxicity of lymphocytes from patients with "acquired" and sex-linked agammaglobulinaemia.

Authors:  E Lieber; S D Douglas; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1971-11       Impact factor: 4.330

6.  Cytotoxic action of stimulated lymphocytes on allogenic and autologous erythrocytes.

Authors:  P Perlmann; H Perlmann; G Holm
Journal:  Science       Date:  1968-04-19       Impact factor: 47.728

7.  Lymphocytes in congenital immunological deficiency diseases.

Authors:  S P Gotoff
Journal:  Clin Exp Immunol       Date:  1968-10       Impact factor: 4.330

8.  Antibody-dependent lymphoid cell-mediated cytotoxicity: no requirement for thymus-derived lymphocytes.

Authors:  J A Van Boxel; J D Stobo; W E Paul; I Green
Journal:  Science       Date:  1972-01-14       Impact factor: 47.728

9.  Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia.

Authors:  G Holm; P Perlmann; B Johansson
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

10.  Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia.

Authors:  H M Grey; E Rabellino; B Pirofsky
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808
View more
  5 in total

1.  Cell-mediated cytotoxicity. Characterization of the effector cells.

Authors:  M M De Bracco; M A Isturiz; J A Manni
Journal:  Immunology       Date:  1976-03       Impact factor: 7.397

2.  Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; E I Beissner; J Gluckman; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

3.  Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.

Authors:  A S Fauci; J E Balow; K R Pratt
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

4.  Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.

Authors:  L C Altman; R Snyderman; R M Blaese
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

5.  Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function.

Authors:  A S Fauci
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.